Theriva Biologics Files 2024 10-K
Ticker: TOVX · Form: 10-K · Filed: Mar 6, 2025 · CIK: 894158
| Field | Detail |
|---|---|
| Company | Theriva Biologics, Inc. (TOVX) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, financials
TL;DR
Theriva Biologics filed its 2024 10-K. Check financials.
AI Summary
Theriva Biologics, Inc. filed its 2024 10-K on March 6, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Synthetic Biologics, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located in Rockville, Maryland.
Why It Matters
This filing provides a comprehensive overview of Theriva Biologics' financial performance and business operations for the fiscal year 2024, crucial for investors assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Theriva Biologics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-03-06 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- Theriva Biologics, Inc. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-06 (date) — Filing Date
- Synthetic Biologics, Inc. (company) — Former Company Name
- Rockville, MD (location) — Business Address
FAQ
What was Theriva Biologics' former company name?
Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc., with a name change date of March 5, 2012.
What is Theriva Biologics' Standard Industrial Classification code?
Theriva Biologics, Inc. is classified under SIC code 2834, Pharmaceutical Preparations.
In which state is Theriva Biologics, Inc. incorporated?
Theriva Biologics, Inc. is incorporated in Nevada (NV).
What is the business address of Theriva Biologics, Inc.?
The business address is 9605 Medical Center Drive, Suite 270, Rockville, MD 20850.
When did Theriva Biologics, Inc. file its 10-K for the fiscal year ending December 31, 2024?
The company filed its 10-K on March 6, 2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding Theriva Biologics, Inc. (TOVX).